Health Outcomes Research in Medicine
Volume 3, Issue 1 , Pages e45-e54 , February 2012

Health Care Utilization and Costs in Patients with Generalized Anxiety Disorder Initiating Add-on Therapy with Benzodiazepines

  • Ariel Berger, MPH

      Affiliations

    • Policy Analysis Inc. (PAI), Brookline, Mass
    • Corresponding Author InformationCorresponding Author: Ariel Berger, MPH, Policy Analysis Inc. (PAI), Four Davis Court, Brookline, MA 02445.
  • ,
  • John Edelsberg, MD, MPH

      Affiliations

    • Policy Analysis Inc. (PAI), Brookline, Mass
  • ,
  • Vamsi Bollu, PhD, MBA

      Affiliations

    • Novartis Pharmaceuticals Corporation, East Hanover, NJ
  • ,
  • Jose Ma. J. Alvir, DrPH

      Affiliations

    • Pfizer Inc., New York, NY
  • ,
  • Ashish Dugar, PhD, MBA

      Affiliations

    • Pfizer Inc., New York, NY
  • ,
  • Ashish V. Joshi, PhD

      Affiliations

    • Pfizer Inc., New York, NY
  • ,
  • Gerry Oster, PhD

      Affiliations

    • Policy Analysis Inc. (PAI), Brookline, Mass

Title About Type File Size
Appendix 	Other
0 MB

Please note that add-on components may require plug-in applications.

 Policy Analysis Inc. received financial support from Pfizer Inc. (New York, NY) for the conduct of this analysis and development of this manuscript.

 At the time this research was undertaken, Vamsi Bollu, Jose Alvir, Ashish Dugar, and Ashish Joshi were employees of Pfizer Inc. The analyses were conducted by Ariel Berger, John Edelsberg, and Gerry Oster, all of whom are employees of Policy Analysis Inc.

 All authors met criteria for authorship (ie, conceptualization or study design, analysis or interpretation of data, manuscript preparation or review).

PII: S1877-1319(11)00043-7

doi: 10.1016/j.ehrm.2011.11.002

Health Outcomes Research in Medicine
Volume 3, Issue 1 , Pages e45-e54 , February 2012